Get the Stockscreener App
0.00
100.00%
-0.3207
InVivo Therapeutics Holdings Corp stock is currently priced at $0.00, with a 24-hour trading volume of 0.
It has seen a -100.00% decreased in the last 24 hours and a -100.00% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $0.3436 pivot point. If it approaches the $0.1701 support level, significant changes may occur.
Previous Close:
$0.3207
Open:
$0
24h Volume:
0
Market Cap:
$995.92K
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
0.00
EPS:
-4.4
Net Cash Flow:
-
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1D Range:
$0.00
$0.00
52W Range:
$0.00
$1.64
InVivo Therapeutics Holdings Corp Stock (NVIV) Company Profile
Name
InVivo Therapeutics Holdings Corp
Sector
Industry
Phone
617-863-5500
Address
One Kendall Square, Floor 4 Building 1400 East, Cambridge, MA
InVivo Therapeutics Holdings Corp Stock (NVIV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-05-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-21-16 | Initiated | Ladenburg Thalmann | Buy |
| Jul-07-16 | Initiated | Raymond James | Strong Buy |
InVivo Therapeutics Holdings Corp Stock (NVIV) Latest News
Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Why Disney Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Benzinga
Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Dow Jumps Over 100 Points; Eli Lilly Posts Upbeat Earnings
Benzinga
Why Palantir Technologies Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Benzinga
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
InVivo Therapeutics Holdings Corp Stock (NVIV) Financials Data
There is no financial data for InVivo Therapeutics Holdings Corp (NVIV). Check out other stocks for more information.
About InVivo Therapeutics Holdings Corp
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. It is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold for implantation at the site of injury within a spinal cord. InVivo Therapeutics Holdings Corp. has research collaboration with the Q Therapeutics, Inc. for the evaluation of the combination of PLGA-PLL based Neuro-Spinal Scaffold with adult neural progenitor cells, including those from induced pluripotent stem cells. The company was founded in 2005 and is headquartered in Cambridge, Massachusetts.
3.69%
0.93%
Cap:
|
Volume (24h):